Godavari Bioref. Q2 FY27 Results (NSE: GODAVARIB)
Signal: Loss widened
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹549.24 Cr | +27.5% | -1.5% |
| EBIT | ₹-0.35 Cr | +98.0% | |
| Net profit | ₹-15.24 Cr | +29.4% | |
| EPS | ₹-2.98 | -70.3% | |
| EBIT margin | -0.06% |
P&L walk
Revenue recovered to ₹54924.08 lakh, up 27.5% YoY but down 1.5% QoQ; gross margin improved modestly to about 21.8%, yet segment operating profit remained a ₹35.35 lakh loss and finance costs of ₹1539.18 lakh drove the ₹1524.08 lakh PAT loss.
Research and educational content only. Not investment advice.